HR Multi-Attribute Method for Biopharma Analysis

Topic Significance

The HR multi-attribute method streamlines comprehensive characterization of biopharmaceuticals by combining high resolution liquid chromatography with accurate mass spectrometry. This approach addresses the need for confident identification and quantitation of critical quality attributes such as post translational modifications and deamidation, supporting regulatory compliance and product consistency.

Objectives and Study Overview

The study aims to present an end-to-end, vendor-verified HR MAM workflow offering robust performance from research to routine QC. Key goals include demonstration of peptide mapping, critical quality attribute monitoring, new peak detection, and seamless data integrity through compliant software.

Applied Instrumentation

• Thermo Scientific Pierce BSA Protein Digest Standard
• Thermo Scientific Vanquish Horizon UHPLC System
• Thermo Scientific Accucore Vanquish C18+ UHPLC Column (1.5 µm solid core)
• Thermo Scientific Q Exactive Plus Hybrid Quadrupole-Orbitrap Mass Spectrometer
• BioPharma Finder software with MS2 prediction algorithm for PTM analysis
• Chromeleon Chromatography Data System (CFR 21 Part 11 compliant)

Main Results and Discussion

The workflow demonstrates exceptional separation efficiency, achieving sharp peaks and low retention time variation for reliable quantitation. The Orbitrap mass analyzer provided ±3 ppm mass accuracy over five orders of dynamic range, enabling detection of low-level modifications. Dedicated software tools improved confidence in peptide identification, PTM localization, and novel impurity detection while minimizing false positives in lot release testing.

Benefits and Practical Applications

• Comprehensive monitoring of critical quality attributes in mAb and protein therapeutics
• High-throughput routine QC with robust reproducibility and system suitability verification
• Accurate quantitation of PTMs and sequence variants for regulatory submissions
• Automated data processing and reporting ensuring data integrity in QA/QC environments

Future Trends and Opportunities

Advances in AI-driven data analysis, increased automation, and integration of multi-omics data are expected to further enhance MAM workflows. Emerging high-throughput mass spectrometers and microflow LC systems may reduce analysis time and solvent consumption, expanding routine application in biopharmaceutical manufacturing.

Conclusion

The Thermo Scientific HR MAM workflow provides a validated, end-to-end solution for comprehensive biopharmaceutical characterization, combining state-of-the-art instrumentation and software. Its high resolution, accuracy, and regulatory-compliant data management facilitate both research and routine QC, ensuring product quality and process understanding.